MiMedx Group
(NASDAQ) MDXG
MiMedx Group Financials at a Glance
Market Cap
$586.84M
Revenue (TTM)
$418.63M
Net Income (TTM)
$48.58M
EPS (TTM)
$0.32
P/E Ratio
12.18
Dividend
$0.00
Beta (Volatility)
1.31 (Average)
Dividend
$0.00
Beta (Volatility)
1.31 (Average)
Price
$3.95
Volume
48,711
Open
$3.99
Price
$3.95
Volume
48,711
Open
$3.99
Previous Close
$3.95
Daily Range
$3.94 - $4.09
52-Week Range
$3.77 - $7.99
Dividend
$0.00
Beta (Volatility)
1.31 (Average)
Price
$3.95
Volume
48,711
Open
$3.99
Previous Close
$3.95
Daily Range
$3.94 - $4.09
52-Week Range
$3.77 - $7.99
MDXG News
MDXG: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MiMedx Group
Industry
Biotechnology
Sector
Health CareEmployees
808
CEO
Joe Capper, MBA
Website
www.mimedx.comHeadquarters
Marietta, GA 30062, US
MDXG Financials
Key Financial Metrics (TTM)
Gross Margin
83%
Operating Margin
15%
Net Income Margin
12%
Return on Equity
22%
Return on Capital
23%
Return on Assets
14%
Earnings Yield
8.21%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$586.84M
Shares Outstanding
148.57M
Volume
48.71K
Short Interest
0.00%
Avg. Volume
1.04M
Financials (TTM)
Gross Profit
$345.62M
Operating Income
$63.89M
EBITDA
$82.93M
Operating Cash Flow
$74.00M
Capital Expenditure
$1.03M
Free Cash Flow
$72.97M
Cash & ST Invst.
$166.12M
Total Debt
$22.53M
MiMedx Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$118.09M
+27.1%
Gross Profit
$99.04M
+30.3%
Gross Margin
83.86%
N/A
Market Cap
$586.84M
N/A
Market Cap/Employee
$701.12K
N/A
Employees
837
N/A
Net Income
$15.19M
+104.2%
EBITDA
$25.42M
+79.8%
Quarterly Fundamentals
Net Cash
$143.59M
+80.4%
Accounts Receivable
$75.71M
+35.6%
Inventory
$25.34M
+6.4%
Long Term Debt
$19.71M
-12.5%
Short Term Debt
$2.82M
+22.2%
Return on Assets
14.18%
N/A
Return on Invested Capital
22.95%
N/A
Free Cash Flow
$24.58M
+30.9%
Operating Cash Flow
$24.96M
+32.9%